Diabetic retinopathy is associated with insulin resistance and cardiovascular autonomic dysfunction in type 2 diabetic patients

Hypertension Research

Volumn 32, Issue 4, 2009, Pages 299-305

  Anan, Futoshi ^a   Takayuki, Masaki ^b   Takahashi, Naohiko ^b   Nakagawa, Mikiko ^b   Eshima, Nobuoki ^c   Saikawa, Tetsunori ^b   Yoshimatsu, Hironobu ^b  

^a OITA RED CROSS HOSPITAL   (Japan)

^b OITA UNIVERSITY   (Japan)

^c OITA UNIVERSITY   (Japan)

Author keywords

123I metaiodobenzylguanidine scintigraphy; Baroreflex sensitivity; Diabetic retinopathy; Insulin resistance

Indexed keywords

ALPHA GLUCOSIDASE INHIBITOR; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EPALRESTAT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; NORADRENALIN; SULFONYLUREA;

ADULT; ARTICLE; AUTONOMIC DYSFUNCTION; AUTONOMIC NERVOUS SYSTEM FUNCTION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CONTROLLED STUDY; DIABETIC RETINOPATHY; DIET RESTRICTION; DISEASE ASSOCIATION; FEMALE; HEART RATE VARIABILITY; HEART SCINTISCANNING; HOMEOSTASIS; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NORADRENALIN BLOOD LEVEL; PRESSORECEPTOR REFLEX;

3-IODOBENZYLGUANIDINE; ANTHROPOMETRY; AUTONOMIC NERVOUS SYSTEM DISEASES; BAROREFLEX; BODY COMPOSITION; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; ECHOCARDIOGRAPHY; FEMALE; HEART RATE; HUMANS; HYPERTENSION; INSULIN RESISTANCE; JAPAN; LOGISTIC MODELS; MALE; MIDDLE AGED; NOREPINEPHRINE;

EID: 77952298245     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2009.8     Document Type: Article

References (42)

1. Klein R, Klein BE, Moss SE, Cruickshanks KJ. Association of ocular disease and mortality in a diabetic population. Arch Ophthalmol 1999; 117: 1487-1495. (Pubitemid 29536476)
2. Rajala U, Pajunpää H, Koskela P, Keinänen-Kiukaanniemi S. High cardiovascular disease mortality in subjects with visual impairment caused by diabetic retinopathy. Diabetes Care 2000; 23: 957-961. (Pubitemid 30480023)
3. van Hecke MV, Dekker JM, Stehouwer CD, Polak BC, Fuller JH, Sjolie AK, Kofinis A, Rottiers R, Porta M, Chaturvedi N, EURODIAB prospective complications study. Diabetic retinopathy is associated with mortality and cardiovascular disease incidence: the EURODIAB prospective complications study. Diabetes Care 2005; 28: 1383-1389.
4. Juutilainen A, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Retinopathy predicts cardiovascular mortality in type 2 diabetic men and women. Diabetes Care 2007; 30: 292-299. (Pubitemid 46198333)
5. Tsuji H, Larson MG, Venditti Jr FJ, Manders ES, Evans JC, Feldman CL, Levy D. The Framingham Study. Circulation 1996; 94: 2850-2855.
6. La Rovere MT, Bigger Jr JT, Marcus FI, Mortara A, Schwartz PJ. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infraction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infraction) Investigators. Lancet 1998; 351: 478-484. (Pubitemid 28070094)
7. 123I- metaiodobenzylguanidine scintigraphy. Metabolism 2007; 56: 919-924.
8. 123I-metaiodobenzylguanidine myocardial scintigraphy in type 2 diabetic patients. Eur J Nucl Med Mol Imaging 2007; 34: 28-35.
9. 123I-metaiodobenzylguanidine myocardial scintigraphy in type 2 diabetic patients. Eur J Nucl Med Mol Imaging 2007; 34: 1189-1197.
10. Hadjadj S, Péan F, Gallois Y, Passa P, Aubert R, Weekers L, Rigalleau V, Bauduceau B, Bekherraz A, Roussel R, Dussol B, Rodier M, Marechaud R, Lefebvre PJ, Marre M. Genesis France-Belgium Study. Different patterns of insulin resistance in relatives of type 2 diabetic patients with retinopathy or nephropathy. Diabetes Care 2004; 27: 2661-2668.
11. Parvanova A, Iliev I, Filipponi M, Dimitrov BD, Vedovato M, Tiengo A, Trevisan R, Remuzzi G, Ruggenenti P. Insulin resistance and proliferative retinopathy crosssectional, case-control study in 115 patients with type 2 diabetes. J Clin Endorinol Metab 2004; 89: 4371-4376. (Pubitemid 39244440)
12. Gerritsen J, TenVoorde BJ, Dekker JM, Kingma R, Kostense PJ, Bouter LM, Heethaar RM. Measures of cardiovascular autonomic dysfunction nervous function: agreement, reproducibility, and reference values in middle age and elderly subjects. Diabetologia 2003; 46: 330-338. (Pubitemid 36547587)
13. 123I-MIBG. J Nucl Med 1999; 40: 6-11.
14. Spallone V, Menzinger G. Diagnosis of cardiovascular autonomic neuropathy in diabetes. Diabetes 1997; 46: S67-S76. (Pubitemid 27377402)
15. Watanabe K, Sekiya M, Tsuruoka T, Funada J, Kameoka H, Miyagawa M, Kohara K. Relationship between insulin resistance and cardiac sympathetic nervous function in essential hypertension. J Hypertens 1999; 17: 1161-1168. (Pubitemid 29389564)
16. Diabetic Retinopathy Study Research Group. Report 7: a modification of the Airlie House classification of diabetic retinopathy. Invest Ophthalmol Vis Sci 1981; 21: 210-226.
17. Early Treatment Diabetic Retinopathy Study Research Group. Fundus photographic risk factors for progression of diabetic retinopathy: ETDRS report number 12. Ophthalmology 1991; 98: 823-833.
18. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Boudier HA, Zanchetti A. ESH-ESC Task Force on the Management of Arterial Hypertension 2007 ESH-ESC practice guidelines for the management of arterial hypertension: ESH-ESC task force on the management of arterial hypertension. J Hypertens 2007; 25: 1751-1762.
19. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
20. Liao D, Sloan RP, Cascio WE, Folsom AR, Liese AD, Evans GW, Cai J, Sharrett AR. Multiple metabolic syndrome is associated with lower heart rate variability. The Atherosclerosis Risk in Communities Study. Diabetes Care 1998; 21: 2116-2122.
21. Sato T, Nishinaga M, Kawamoto A, Ozawa T, Takatsuji H. Accuracy of a continuous blood pressure monitor based on arterial tonometry. Hypertension 1993; 21: 866-874.
22. Malliani A, Pagani M, Lombardi F, Cerutti S. Cardiovascular neural regulation explored in the frequency domain. Circulation 1991; 84: 482-492.
23. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 15: 539-553.
24. Yudkin JS. Abnormalities of coagulation and fibrinolysis in insulin resistance. Diabetes Care 1999; 22: C25-C30.
25. Kurioka S, Koshimura K, Murakami Y, Nishiki M, Kato Y. Reverse correlation between urine nitric oxide metabolites and insulin resistance in patients with type 2 diabetes mellitus. Endocr J 2000; 47: 77-81.
26. Schmid H, Schaan B, Cecconello F, Maestri T, Neumann C. Proliferative diabetic retinopathy is related to cardiovascular autonomic neuropathy in non-insulin-dependent diabetes mellitus. Diabtes Res Clin Pract 1995; 29: 163-168.
27. Duvnjak L, Vuckoviæ S, Pepeonik Z, Metelko Z. Relationship between autonomic neuropathy, 24-hr blood pressure and retinopathy in normoalbuminuric and normotensive Type 1 diabetic patients. Diabetes Nutr Metab 2003; 16: 102-108.
28. Kinjyo Y, Kajiyama S, Fujiwara H, Kanegawa N, Saji H. Influence of the polyol pathway on transporter reduction in diabetic cardiac sympathetic nerve: implication for heterogeneous accumulation of MIBG. Eur J Nucl Med Imaging 2005; 32: 438-442.
29. 123I] metaiodobenzylguanidine. Diabetes 1992; 41: 1069-1075.
30. Abiko T, Abiko A, Clermont AC, Shoelson B, Horio N, Takahashi J, Adamis AP, King GL, Bursell SE. Characterization of retinal leukostasis and hemodynamics in insulin resistance and diabetes: role of oxidants and protein kinase-C activation. Diabetes 2003; 52: 829-837.
31. Ghiadoni L, Donald AE, Cropley M, Mullen MJ, Oakley G, Taylor M, O'Connor G, Betteridge J, Klein N, Steptoe A, Deanfield JE. Mental stress induces transient endothelial dysfunction in humans. Circulation 2000; 102: 2473-2478.
32. Hijmering ML, Stroes ES, Olijhoek J, Hutten BA, Blankestijn PJ, Rabelink TJ. Sympathetic activation markedly reduces endothelium-dependent, flow-mediated vasodilatation. J Am Coll Cardiol 2002; 39: 683-688.
33. Yilmaz MI, Sonmez A, Acikel C, Celik T, Bingol N, Pinar M, Bayraktar Z, Ozata M. Adiponectin may play a part in the pathogenesis of diabetic retinopathy. Eur J Endocrinol 2004; 151: 135-140.
34. Singleton JR, Smith AG, Russell JW, Feldman EL. Microvascular complications of impaired glucose tolerance. Diabetes 2003; 52: 2867-2873.
35. Annonu AK, Fattah AA, Mokhtar MS, Ghareeb S, Elhendy A. Left ventricular systolic and diastolic in asymptomatic patients with non-insulin-dependent diabetes mellitus. J Am Soc Echocardiogr 2001; 14: 885-891.
36. Gavras HP. Issues in hypertension: drug tolerability and special populations. Am J Hypertens 2001; 14 (Part 2): 231S-236S.
37. Lender D, Arauz-Pacheco C, Breen L, Mora-Mora P, Ramirez LC, Raskin P. A double blind comparison of the effects of amlodipine and enalapril on insulin sensitivity in hypertensive patients. Am J Hypertens 1999; 12: 298-303.
38. Kontopoulos AG, Athyros VG, Didangelos TP, Papageorgiou AA, Avramidis MJ, Mayroudi MC, Karamitsos DT. Effect of chronic quinapril administration on heart rate variability in patients with diabetic autonomic neuropathy. Diabetes Care 1997; 20: 355-361.
39. Rodgers JE, Patterson JH. Angiotensin II-receptor blockers: clinical relevance and therapeutic role. Am J Health Syst Pharm 2001; 58: 671-683.
40. Huang EJ, Kuo WW, Chen YJ, Chen TH, Chang MH, Lu MC, Tzang BS, Hsu HH, Huang CY, Lee SD. Homocysteine and other biochemical parameters in type 2 diabetes mellitus with different diabetic duration or diabetic retinopathy. Clin Chim Acta 2006; 366: 293-298.
41. Hotta N, Akanuma Y, Kawamori R, Matsuoka K, Oka Y, Shichiri M, Toyota T, Nakashima M, Yoshimura I, Sakamoto N, Shigeta Y. Long-term clinical effects on epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy: the 3-year, multicenter, comparative Aldose Reductase Inhibitor-Diabetes Complications Trial. Diabetes Care 2006; 29: 1538-1544.
42. Yamashina S, Yamazaki J. Role of MIBG myocardial scintigraphy in the assessment of heart failure: the need to establish evidence. Eur J Nucl Med Mol Imaging 2004; 31: 1353-1355.